Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23245740)

1.

In Reply to 'Neutrophil Gelatinase-Associated Lipocalin (NGAL), Neutrophils, and CKD: Which Comes First?'.

Bhavsar NA, Coresh J, Astor BC.

Am J Kidney Dis. 2013 Jan;61(1):184. doi: 10.1053/j.ajkd.2012.10.008. No abstract available.

PMID:
23245740
2.

Neutrophil gelatinase-associated lipocalin (NGAL), neutrophils, and CKD: which comes first?

Lippi G, Cervellin G.

Am J Kidney Dis. 2013 Jan;61(1):184. doi: 10.1053/j.ajkd.2012.06.031. No abstract available.

PMID:
23245739
3.

Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.

Bhavsar NA, Köttgen A, Coresh J, Astor BC.

Am J Kidney Dis. 2012 Aug;60(2):233-40. doi: 10.1053/j.ajkd.2012.02.336. Epub 2012 Apr 28.

4.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.

Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, Hansen PR, Parving HH, Rossing P.

Diabet Med. 2010 Oct;27(10):1144-50. doi: 10.1111/j.1464-5491.2010.03083.x.

PMID:
20854382
5.

Diagnostic test for early detection of acute kidney injury.

Hollmen M.

Expert Rev Mol Diagn. 2011 Jul;11(6):553-5. doi: 10.1586/erm.11.35. No abstract available.

PMID:
21745008
6.

[Clinical implication of a novel biomarker Ngal in CKD].

Mori K, Mukoyama M, Kuwabara T, Kasahara M, Yokoi H, Nakao K.

Nihon Rinsho. 2009 Jun;67(6):1233-41. Review. Japanese.

PMID:
19507520
7.

Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication.

Gil HW, Yang JO, Lee EY, Hong SY.

Clin Toxicol (Phila). 2009 Nov;47(9):870-5. doi: 10.3109/15563650903306651.

PMID:
19827907
8.

NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.

Holzscheiter L, Beck C, Rutz S, Manuilova E, Domke I, Guder WG, Hofmann W.

Clin Chem Lab Med. 2014 Apr;52(4):537-46. doi: 10.1515/cclm-2013-0693.

PMID:
24243749
9.

Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).

Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG.

Am J Kidney Dis. 2012 Dec;60(6):904-11. doi: 10.1053/j.ajkd.2012.05.014. Epub 2012 Jun 30.

10.

[Evaluation of tubulointerstitial injury by new biomarkers].

Mori K, Mukoyama M, Kasahara M, Nakao K.

Nihon Jinzo Gakkai Shi. 2011;53(4):596-9. Review. Japanese. No abstract available.

PMID:
21688478
11.

[Early biomarker for AKI].

Mori K, Mukoyama M, Nakao K.

Nihon Jinzo Gakkai Shi. 2010;52(5):566-71. Review. Japanese. No abstract available.

PMID:
20715588
12.

Urinary neutrophil gelatinase-associated lipocalin (NGAL) for the detection of acute kidney injury after orthotopic liver transplantation.

Feldkamp T, Bienholz A, Kribben A.

Nephrol Dial Transplant. 2011 May;26(5):1456-8. doi: 10.1093/ndt/gfr146. Epub 2011 Apr 12. No abstract available.

13.

Evaluating new biomarkers for acute kidney injury: putting the horse before the cart.

Carter JL, Lamb EJ.

Am J Kidney Dis. 2014 Apr;63(4):543-6. doi: 10.1053/j.ajkd.2014.01.005. No abstract available.

PMID:
24670481
14.

[Neutrophil gelatinase-associated lipocalin (NGAL): a biomarker beyond the confines of nephrology].

Bolignano D.

G Ital Nefrol. 2010 Jan-Feb;27(1):6. Italian. No abstract available.

PMID:
20191452
15.

Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.

Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML, Deng RT, Zheng L, Wang SB, Pen LF, Wang Q.

Endocrine. 2012 Feb;41(1):82-8. doi: 10.1007/s12020-011-9509-7. Epub 2011 Jul 21.

PMID:
21779943
16.

Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin.

Eirin A, Gloviczki ML, Tang H, Rule AD, Woollard JR, Lerman A, Textor SC, Lerman LO.

Nephrol Dial Transplant. 2012 Nov;27(11):4153-61. doi: 10.1093/ndt/gfs370. Epub 2012 Aug 23.

17.

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.

Nielsen SE, Andersen S, Zdunek D, Hess G, Parving HH, Rossing P.

Kidney Int. 2011 May;79(10):1113-8. doi: 10.1038/ki.2010.554. Epub 2011 Jan 26.

PMID:
21270761
18.

Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.

Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, Kim YK.

Diabetes Res Clin Pract. 2012 Aug;97(2):251-7. doi: 10.1016/j.diabres.2012.02.019. Epub 2012 Mar 21.

PMID:
22440044
19.

Early detection of acute kidney injury with neutrophil gelatinase-associated lipocalin.

McCullough PA, El-Ghoroury M, Yamasaki H.

J Am Coll Cardiol. 2011 Apr 26;57(17):1762-4. doi: 10.1016/j.jacc.2010.11.050. No abstract available.

20.

Tubular biomarkers to assess progression of diabetic nephropathy.

Tramonti G, Kanwar YS.

Kidney Int. 2011 May;79(10):1042-4. doi: 10.1038/ki.2011.9.

PMID:
21527942
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk